Sign in
av/genocea-biosciences--big.svg

NASDAQ:GNCA

Genocea Biosciences, Inc.

  • Stock

USD

Last Close

0.00

22/12 19:54

Volume Today

30.27K

Avg: 80.57K

PE Ratio

0.00

PFCF: -

OverviewFinancialsFilingspeopleOwnershipAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Excel Tearsheet
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
asset turnover
0.05
-
0.01
86.83%
0.01
2.17%
0.00
43.73%
0.01
-
0.03
112.50%
cash per share
5.67
-
24.12
325.13%
30.85
27.93%
17.91
41.94%
3.43
80.84%
2.55
25.59%
1.94
23.90%
1.80
7.65%
0.54
69.82%
company equity multiplier
11.01
-
1.55
85.91%
1.25
19.38%
1.53
22.71%
-2.89
288.34%
4.24
246.75%
2.10
50.47%
10.97
421.95%
2.07
81.15%
days of inventory outstanding
days of payables outstanding
days of sales outstanding
24.89
-
dividend yield
ebit per revenue
-27.26
-
-107.68
295.06%
-61.74
42.66%
-205.30
232.52%
-34.58
-
-31.74
8.19%
ebt per ebit
1.04
-
1.06
1.92%
1.03
3.50%
1.03
0.05%
1.03
0.12%
0.70
31.43%
1.00
41.95%
0.93
6.88%
0.64
31.50%
effective tax rate
enterprise value multiple
-9.34
-
-3.77
59.57%
-5.09
34.86%
-2.31
54.69%
-0.66
71.45%
-0.47
28.26%
-0.46
1.73%
-1.25
170.07%
-1.56
24.44%
fixed asset turnover
0.85
-
0.16
81.37%
0.16
4.21%
0.05
70.60%
0.09
-
0.12
31.40%
free cash flow per share
-9.41
-
-14.92
58.45%
-13.46
9.81%
-12.54
6.77%
-13.64
8.76%
-4.02
70.54%
-1.88
53.15%
-1.00
47.13%
gross profit margin
interest coverage
-43.41
-
-34.19
21.23%
-37.03
8.31%
-27.76
25.04%
-32.41
16.75%
-38.71
19.43%
-41.21
6.48%
-34.05
17.38%
46.47
236.48%
inventory turnover
long term debt to capitalization
0.86
-
0.26
69.70%
0.16
40.55%
0.23
49.88%
4.78
1,952.91%
0.57
88.15%
0.35
38.39%
0.48
38.57%
0.13
72.52%
net income per ebt
1
-
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
net profit margin
-28.46
-
-114.60
302.63%
-63.41
44.67%
-210.95
232.69%
-32.17
-
-20.23
37.11%
operating cash flow per share
-9.23
-
-14.14
53.12%
-12.54
11.28%
-11.83
5.73%
-13.31
12.57%
-4.00
69.99%
-1.83
54.25%
-0.94
48.72%
operating profit margin
-27.26
-
-107.68
295.06%
-61.74
42.66%
-205.30
232.52%
-34.58
-
-31.74
8.19%
payables turnover
pretax profit margin
-28.46
-
-114.60
302.63%
-63.41
44.67%
-210.95
232.69%
-32.17
-
-20.23
37.11%
price fair value
132.35
-
3.36
97.46%
1.44
57.25%
2.56
78.07%
-5.48
314.21%
3.23
158.86%
1.71
47.14%
11.97
601.59%
2.94
75.46%
receivables turnover
14.67
-
return on assets
-1.32
-
-0.70
46.98%
-0.38
45.87%
-0.71
87.22%
-3.24
357.22%
-0.89
72.44%
-0.74
17.17%
-0.44
40.05%
-0.59
33.64%
return on capital employed
-1.77
-
-0.74
57.94%
-0.39
47.62%
-0.81
108.03%
-32.33
3,889.18%
-1.94
94.00%
-0.84
56.59%
-0.64
24.03%
-1.40
118.54%
return on equity
-14.54
-
-1.09
92.53%
-0.47
56.36%
-1.09
129.74%
9.37
961.12%
-3.79
140.45%
-1.56
58.98%
-4.87
212.90%
-1.23
74.81%
total debt to capitalization
0.87
-
0.26
70.07%
0.16
40.55%
0.27
74.78%
1.73
538.46%
0.67
61.38%
0.37
45.13%
0.73
97.95%
0.29
59.90%

All numbers in USD (except ratios and percentages)